Arno Siever
Impact in
- Pathology and Forensic Medicine top 10%
- Multiple Sclerosis Research Studies
-
- Peripheral Neuropathies and Disorders
Papers in
-
- Multiple Sclerosis Research Studies 4
-
- Sphingolipid Metabolism and Signaling 1
- Cancer therapeutics and mechanisms 1
- Co-authors
- Ralf Gold (3 shared papers)Rebecca Gottschalk (3 shared papers)Philipp von Rosenstiel (3 shared papers)Davorka Tomic (3 shared papers)Cristoforo Comi (1 shared paper)Jacqueline Palace (1 shared paper)Ludwig Kappos (1 shared paper)F. Hoffmann (1 shared paper)
- Partner nations
- GermanySwitzerlandItaly
In The Last Decade
Arno Siever
5 papers receiving 174 citations
Peers
Comparison fields: 5 of 34
- Pathology and Forensic Medicine 147
- Neurology 50
- Hematology 19
- Rheumatology 22
- Molecular Biology 87
Countries citing papers authored by Arno Siever
This map shows the geographic impact of Arno Siever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arno Siever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arno Siever more than expected).
Fields of papers citing papers by Arno Siever
This network shows the impact of papers produced by Arno Siever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arno Siever. The network helps show where Arno Siever may publish in the future.
Co-authors
The 22 scholars most cited alongside Arno Siever, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 104 | |
| 2 | 2009 | 64 | |
| 3 | Safety and tolerability of fingolimod 0.5 mg during the first 4 months of administration in patients with relapsing forms of multiple sclerosis. Results from the open-label, multicentre FIRST study | 2012 | 4 |
| 4 | 1992 | 3 | |
| 5 | Cardiac safety of fingolimod 0.5 mg during the first-dose observation in a 4-month, open-label, multicentre FIRST study in relapsing multiple sclerosis patients | 2012 | 2 |
About Arno Siever
Arno Siever is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Neurology, Infectious Diseases and Oncology, having authored 5 papers that have together received 177 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (4 papers), Peripheral Neuropathies and Disorders (2 papers), Sphingolipid Metabolism and Signaling (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper), Cancer therapeutics and mechanisms (1 paper), Liver Diseases and Immunity (1 paper), Toxin Mechanisms and Immunotoxins (1 paper) and Polyomavirus and related diseases (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (147 citations), Neurology (50 citations), Hematology (19 citations), Rheumatology (22 citations) and Molecular Biology (87 citations). Arno Siever has collaborated with scholars based in Germany, Switzerland and Italy. Frequent co-authors include Ralf Gold, Rebecca Gottschalk, Philipp von Rosenstiel, Davorka Tomic, Cristoforo Comi, Jacqueline Palace, Ludwig Kappos, F. Hoffmann, Michaela Liedtke and Norman Putzki. Their work appears in journals such as Journal of Neurology and European Journal of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.